中国2型糖尿病患者应用门冬胰岛素30与甘精胰岛素的成本-效果分析
吴晶, 贺小宁, 刘艳辉
Cost-Effectiveness Analysis of Insulin Aspart 30 Versus Insulin Glargine in Patients with Type 2 Diabetes in China
WU Jing, HE Xiao-ning, LIU Yan-hui
中国药学杂志
.
2016, (3): 242
-247
.
DOI: 10.11669/cpj.2016.03.021
